DJIA 17,804.80 26.65 0.15%
NASDAQ 4,765.38 16.98 0.36%
S&P 500 2,070.65 9.42 0.46%
market minute promo

58.00 1.35 (2.38%)

REAL-TIME: Last trade at

Extended Hours: $58.52 $0.52 (0.90%)
Quote as of (NYSE)



company name or ticker

Recent Quotes

TEVA $58.00 2.38%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $57.00
Previous Close $56.65
Daily Range $56.54 - $58.61
52-Week Range $38.97 - $58.87
Market Cap $49.6B
P/E Ratio 38.02
Dividend (Yield) $1.09 (2.0%)
Ex-Dividend Date
Dividend Pay Date
11/13/14
12/02/14
Volume 6,051,274
Average Daily Volume 3,998,458
Current FY EPS $5.06

Sector

Healthcare

Industry

Drugs

Teva Pharmaceutical Industries (TEVA) Description

A global pharmaceutical company, Teva develops, produces, and markets generic drugs covering all major treatment categories. Website: http://www.tevapharm.com/

News & Commentary

Pfizer, Inc. Invests in Growth... Literally

Pfizer, Inc. pays $275 million upfront for commercialization rights to Opko Health Inc.'s promising human growth hormone drug.

Health Care Sector Update for 12/19/2014: CRME, TEVA, OREX

Is a Biosimilar (Generic) Top Cancer Drug for You?

Pfizer Ponies Up to Develop Long-acting Growth Hormone

Teva's (TEVA) 2015 Guidance Hit By Generics - Analyst Blog

Teva's (TEVA) 2015 Guidance Hit By Generics - Analyst Blog

UPDATE: Sterne Agee Upgrades Teva Pharmaceutical

Mylan Among First to Launch Generic Celebrex - Analyst Blog

Teva Pharmaceutical TEVA) Stock Up Today on Higher 2015 Profit Estimate

Teva Pharmaceutical Releases 2015 Guidance, Sees Increased Generic Competition

Merck-Cubist Deal On Despite Patent Setback, Shares Fall - Analyst Blog

See More TEVA News...

TEVA's Top Competitors

TEVA $58.00 (2.38%)
Current stock: TEVA
JNJ $105.55 (-1.18%)
Current stock: JNJ
NVS $94.61 (0.04%)
Current stock: NVS
RHHBY $34.47 (-6.59%)
Current stock: RHHBY